Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ARS-853 |
Synonyms | |
Therapy Description |
ARS-853 selectively inhibits KRAS G12C, resulting in a decrease in activated KRAS G12C and potentially leading to reduced growth of KRAS G12C-expressing tumor cells (PMID: 26739882, PMID: 32101243). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ARS-853 | KRAS G12C inhibitor 34 | ARS-853 selectively inhibits KRAS G12C, resulting in a decrease in activated KRAS G12C and potentially leading to reduced growth of KRAS G12C-expressing tumor cells (PMID: 26739882, PMID: 32101243). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|